Riskpilot← Back to searchSign inGet full accessCellproduct Ab
OYActiveY-tunnus 2486958-7Gränden 17Manufacture of other fabricated metal products n.e.c. · NACE 2599Est. 20121 employees
Revenue 2023
EUR 12K
0% vs 2022
EBITDA margin
-24.5%
0% vs 2022
Equity ratio
79.4%
Financial strength
Net profit 2023
EUR -3K
0% vs 2022
| Revenue | EUR 12K | +0% |
| EBITDA | EUR -3K | +0% |
| Net profit | EUR -3K | +0% |
| Total assets | EUR 32K | +10% |
| Equity | EUR 26K | -11% |
| Employees | 1 | — |
Legal name
Cellproduct Ab
Y-tunnus number
2486958-7
Legal form
Osakeyhtiö
NACE code
2599 · Manufacture of other fabricated metal products n.e.c.
Founded
4. heinäkuuta 2012
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-06-30
Financial year
January – December
Signatory rights
Selvitystilan aikana selvitysmies yksin
Company purpose
Bolagets verksamhetsområde är planering och konsultering av metallprodukter. Bolaget kan äga och besitta fastigheter och aktier och därtill hörande verksamhet.
Address
Gränden 17
Phone
+3580500269962
Email
lisen.haggman@hotmail.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenue | 17 | 22 | 12 | 12 |
| Staff expenses | −12 | −12 | −12 | −12 |
| EBITDA | 3 | 8 | −3 | −3 |
| Depreciation & amort. | — | — | — | −0 |
| EBIT | 3 | 8 | −3 | −3 |
| Net financials | −0 | −0 | −0 | −0 |
| Profit before tax | 3 | 8 | −3 | −3 |
| Tax | 1 | 2 | 0 | 0 |
| Net profit | 2 | 6 | −3 | −3 |
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Total assets | 33 | 38 | 29 | 32 |
| Equity | 31 | 35 | 29 | 26 |
| Long-term debt | — | — | — | 0 |
| Short-term debt | 2 | 3 | 1 | 1 |
| Total debt | 2 | 3 | 1 | 7 |
EBITDA margin
-24.5%
This company
15.8%
Market median
-255% vs market
20202023
Equity ratio
79.4%
This company
38.2%
Market median
+108% vs market
20202023
Return on equity
-11.9%
This company
18.4%
Market median
-165% vs market
20202023
Net profit margin
-25.9%
This company
8.1%
Market median
-420% vs market
20202023
Asset turnover
0.36×
This company
1.12×
Market median
-68% vs market
20202023
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20202023
- Annual report 2023Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via PRH / YTJ · Period 2019-07-01 – 2020-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MA Liquidator | Liquidator | 2024 |
| Former (2) | ||
BG Confidential Clerk | Confidential Clerk | 2019 – 2024 |
AJ Deputy Member | Deputy Member | 2012 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Board of Directors | 2012 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cellproduct Ab also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Boris Gustav Häggman | Confidential Clerk | 0 companies |
| Monika Ann-Christine Andersson | Liquidator | 0 companies |
| André John Fredrik Häggman | Deputy Member | 0 companies |
| Lisen Marianne Häggman | Board of Directors | 0 companies |